213 related articles for article (PubMed ID: 8680719)
21. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
22. Histochemical, pharmacological, biochemical and chromatographic evidence that pituitary adenylyl cyclase activating peptide is involved in inhibitory neurotransmission in the taenia of the guinea-pig caecum.
McConalogue K; Furness JB; Vremec MA; Holst JJ; Tornøe K; Marley PD
J Auton Nerv Syst; 1995 Jan; 50(3):311-22. PubMed ID: 7714325
[TBL] [Abstract][Full Text] [Related]
23. Excitatory and inhibitory actions of pituitary adenylate cyclase-activating peptide (PACAP) in the internal anal sphincter smooth muscle: sites of actions.
Rattan S; Chakder S
J Pharmacol Exp Ther; 1997 Nov; 283(2):722-8. PubMed ID: 9353391
[TBL] [Abstract][Full Text] [Related]
24. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
25. Interactive mechanisms among pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide, and parathyroid hormone receptors in guinea pig cecal circular smooth muscle cells.
Motomura Y; Chijiiwa Y; Iwakiri Y; Ochiai T; Nawata H
Endocrinology; 1998 Jun; 139(6):2869-78. PubMed ID: 9607796
[TBL] [Abstract][Full Text] [Related]
26. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
27. Distribution of two VIP-related peptides, helospectin and pituitary adenylate cyclase activating peptide (PACAP), in the human upper respiratory system.
Hauser-Kronberger C; Hacker GW; Albegger K; Muss WH; Sundler F; Arimura A; Dietze O
Regul Pept; 1996 Sep; 65(3):203-9. PubMed ID: 8897643
[TBL] [Abstract][Full Text] [Related]
28. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
29. Involvement of pituitary adenylate cyclase-activating peptide in opossum internal anal sphincter relaxation.
Chakder S; Rattan S
Am J Physiol; 1998 Oct; 275(4):G769-77. PubMed ID: 9756508
[TBL] [Abstract][Full Text] [Related]
30. Region-specific antiproliferative effect of VIP and PACAP-(1-38) on rabbit enteric smooth muscle.
van Assche G; Depoortere I; de Vos R; Geboes K; Janssens JJ; Collins SM; Peeters TL
Am J Physiol; 1999 Jan; 276(1):G303-10. PubMed ID: 9887008
[TBL] [Abstract][Full Text] [Related]
31. Pituitary adenylate cyclase-activating polypeptide- and VIP-induced activation of adenylate cyclase in the porcine non-pigmented ciliary epithelium: effects of antagonists.
Samuelsson-Almén M; Nilsson SF
J Ocul Pharmacol Ther; 1999 Oct; 15(5):389-400. PubMed ID: 10530700
[TBL] [Abstract][Full Text] [Related]
32. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
33. Helodermin, helospectin, and PACAP stimulate cyclic AMP formation in intact bone, isolated osteoblasts, and osteoblastic cell lines.
Lerner UH; Lundberg P; Ransjö M; Persson P; Håkanson R
Calcif Tissue Int; 1994 Apr; 54(4):284-9. PubMed ID: 7914821
[TBL] [Abstract][Full Text] [Related]
34. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain.
Köves K; Arimura A; Görcs TG; Somogyvári-Vigh A
Neuroendocrinology; 1991 Aug; 54(2):159-69. PubMed ID: 1766552
[TBL] [Abstract][Full Text] [Related]
35. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory pathways in the circular muscle of rat jejunum.
Vanneste G; Robberecht P; Lefebvre RA
Br J Pharmacol; 2004 Sep; 143(1):107-18. PubMed ID: 15302684
[TBL] [Abstract][Full Text] [Related]
38. Pituitary adenylate cyclase-activating peptide-immunoreactive nerve fibers in the cat eye.
Elsås T; Uddman R; Sundler F
Graefes Arch Clin Exp Ophthalmol; 1996 Sep; 234(9):573-80. PubMed ID: 8880156
[TBL] [Abstract][Full Text] [Related]
39. Pituitary adenylate cyclase activating peptide, a novel VIP-like gut-brain peptide, relaxes the guinea-pig taenia caeci via apamin-sensitive potassium channels.
Schwörer H; Katsoulis S; Creutzfeldt W; Schmidt WE
Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):511-4. PubMed ID: 1470223
[TBL] [Abstract][Full Text] [Related]
40. The effects of PACAP and VIP on guinea pig tracheal smooth muscle in vitro.
Bhogal R; Sheldrick RL; Coleman RA; Smith DM; Bloom SR
Peptides; 1994; 15(7):1237-41. PubMed ID: 7854975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
